This took the form of a nearly 5-million strong, secondary share issue. Nektar Therapeutics (NASDAQ: NKTR) saw its stock ...

Discover the risks and rewards of Perpetual Stride Preferred Stock's 10% yield. Click for STRD's speculative nature and ...

The board of directors for the Lakeland-based Publix Super Markets Inc. declared the third-quarter dividend on July 1 at ...

National Institute of Health and Care Excellence (NICE) representatives believe it vital not to spread misinformation about ...

Shift4 Payments' FOUR-A preferred offers solid dividend coverage and growth exposure, but lacks risk-adjusted appeal vs.

Amaze Holdings, Inc. (NYSE American:AMZE) (”Amaze” or the “Company”),a global leader in creator-powered commerce, today announced the results of its annual stockholders’ meeting held today.

The offering was made only by means of an effective shelf registration statement on Form S-3 (File No. 333-280793), including a preliminary prospectus supplement and final prospectus supplement ...

Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced its plans to ...

Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the 'Company”), a late-stage clinical biopharmaceutical company focused on the ...

ELOC Issuance Proposal: Stockholders approved the issuance of 20% or more of the Company's issued and outstanding common stock in connection with the securities purchase agreement dated May 6, 2025.

The net proceeds of the offering shall be used for working capital and general corporate purposes. Based on its current operating assumptions, Cyclacel expects this financing, together with Cyclacel's ...